Abstract
Mediastinal Cancer: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make the corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM7 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the commoner non-carcinoma malignancies that are encountered at this site in diagnostic practice.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
1AFP: α-fetoprotein, HCG: β subunit human chorionic gonadotrophin, LDH: lactate dehydrogenase.
Bibliography
Anastasiadis K, Ratatunga C. The thymus gland: diagnosis and surgical management. 1st ed. Berlin/New York: Springer; 2007.
Burke A, Jeudy Jr J, Virmani R. Cardiac tumours; an update. Heart. 2008;94:117–23.
Den Bakker MA, Oosterhuis JW. Tumours and tumour-like conditions of the thymus other than thymoma: a practical approach. Histopathology. 2009;54:69–89.
Detterbeck F. International thymic malignancies interest group: a way forward. J Thorac Oncol. 2010;5:S365–70.
Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran C. The Masaoka-Koga stage classification of thymic malignancies: clarification and definition of terms. J Thorac Oncol. 2011a;6:S1710–6.
Detterbeck FC, Moran C, Huang J, Suster S, Walsh G, Kaiser L, et al. Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol. 2011b;6:S1730–8.
Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485–92.
Muller-Hermelink HK, Marx A, Kircher T. Advances in the diagnosis and classification of thymic epithelial tumours. In: Anthony PP, MacSween RNM, editors. Recent advances in histopathology, vol. 16. Edinburgh: Churchill Livingstone; 1994. p. 49–72.
Salter DM. Pulmonary and thoracic sarcomas. Curr Diagn Pathol. 2006;12:409–17.
The Royal College of Pathologists. Dataset for the histological reporting of thymic epithelial tumours. Accessed at http://www.rcpath.org/index.asp?PageID=254.
Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. WHO classification of tumours. Pathology and genetics. Tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Allen, D.C. (2013). Mediastinal Cancer. In: Histopathology Reporting. Springer, London. https://doi.org/10.1007/978-1-4471-5263-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5263-7_19
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5262-0
Online ISBN: 978-1-4471-5263-7
eBook Packages: MedicineMedicine (R0)